Genetic diagnosis of Mendelian disorders via RNA sequencing

Abstract

Across a variety of Mendelian disorders, ∼50–75% of patients do not receive a genetic diagnosis by exome sequencing indicating disease-causing variants in non-coding regions. Although genome sequencing in principle reveals all genetic variants, their sizeable number and poorer annotation make prioritization challenging. Here, we demonstrate the power of transcriptome sequencing to molecularly diagnose 10% (5 of 48) of mitochondriopathy patients and identify candidate genes for the remainder. We find a median of one aberrantly expressed gene, five aberrant splicing events and six mono-allelically expressed rare variants in patient-derived fibroblasts and establish disease-causing roles for each kind. Private exons often arise from cryptic splice sites providing an important clue for variant prioritization. One such event is found in the complex I assembly factor TIMMDC1 establishing a novel disease-associated gene. In conclusion, our study expands the diagnostic tools for detecting non-exonic variants and provides examples of intronic loss-of-function variants with pathological relevance.

References 68

1. 1.
   Whole exome sequencing of suspected mitochondrial patients in clinical practice · 2015

   No notice
2. 2.

   1000 Genomes Project Consortium.. A global reference for human genetic variation. Nature 526, 68–74 (2015 ).

   Not in our library10.1038/nature15393

3. 3.

   Sudmant P. H.. An integrated map of structural variation in 2,504 human genomes. Nature 526, 75–81 (2015 ).

   Not in our library10.1038/nature15394

4. 4.

   Taylor J. C.. Factors influencing success of clinical genome sequencing across a broad spectrum of disorders. Nat. Genet. 47, 717–726 (2015 ).

   Not in our library10.1038/ng.3304

5. 5.
   The impact of rare variation on gene expression across tissues · 2017

   No notice
6. 6.
   Aberrant gene expression in humans. · 2015

   Not checked
7. 7.

   Guan J.. Exploiting aberrant mRNA expression in autism for gene discovery and diagnosis. Hum. Genet. 135, 1–15 (2016 ).

   Not in our library10.1007/s00439-016-1673-7

8. 8.

   Zhao J.. A burden of rare variants associated with extremes of gene expression in human peripheral blood. Am. J. Hum. Genet. 98, 299–309 (2016 ).

   Not in our library10.1016/j.ajhg.2015.12.023

9. 9.

   Albers C. A. Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome. Nat. Genet. 44, 435–439 S1-2 (2012 ).

   Not in our library10.1038/ng.1083

10. 10.

    Reinius B. & Sandberg R. Random monoallelic expression of autosomal genes: stochastic transcription and allele-level regulation. Nat. Rev. Genet. 16, 653–664 (2015 ).

    Not in our library10.1038/nrg3888

11. 11.

    Eckersley-Maslin M. A. & Spector D. L. Random monoallelic expression: regulating gene expression one allele at a time. Trends Genet. 30, 237–244 (2014 ).

    Not in our library10.1016/j.tig.2014.03.003

12. 12.

    Tazi J., Bakkour N. & Stamm S. Alternative splicing and disease. Biochim. Biophys. Acta 1792, 14–262009.

    Not in our library10.1016/j.bbadis.2008.09.017

13. 13.

    Scotti M. M. & Swanson M. S. RNA mis-splicing in disease. Nat. Rev. Genet. 17, 19–32 (2015 ).

    Not in our library10.1038/nrg.2015.3

14. 14.

    Singh R. K. & Cooper T. A. Pre-mRNA splicing in disease and therapeutics. Trends Mol. Med. 18, 472–482 (2012 ).

    Not in our library10.1016/j.molmed.2012.06.006

15. 15.

    Xiong H. Y.. The human splicing code reveals new insights into the genetic determinants of disease. Science 347, 1254806–1254806 (2015 ).

    Not in our library10.1126/science.1254806

16. 16.

    Muntoni F., Torelli S. & Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol. 2, 731–740 (2003 ).

    Not in our library10.1016/s1474-4422(03)00585-4

17. 17.

    Gonorazky H.. RNAseq analysis for the diagnosis of muscular dystrophy. Ann. Clin. Transl. Neurol. 3, 55–60 (2016 ).

    Not in our library10.1002/acn3.267

18. 18.

    Morel C. F.. A LMNA splicing mutation in two sisters with severe dunnigan-type familial partial lipodystrophy type 2. J. Clin. Endocrinol. Metab. 91, 2689–2695 (2006 ).

    Not in our library10.1210/jc.2005-2746

19. 19.

    Qu Y.. A rare variant (c.863G>T) in exon 7 of SMN1 disrupts mRNA splicing and is responsible for spinal muscular atrophy. Eur. J. Hum. Genet. 24, 864–870 (2016 ).

    Not in our library10.1038/ejhg.2015.213

20. 20.

    Gorman G. S.. Mitochondrial diseases. Nat. Rev. Dis. Primer 2, 16080 (2016 ).

    Not in our library10.1038/nrdp.2016.80

21. 21.

    Elstner M., Andreoli C. & Ahting U. MitoP2: an integrative tool for the analysis of the mitochondrial proteome. Mol. Biotechnol. 40, 306–315 (2008 ).

    Not in our library10.1007/s12033-008-9100-5

22. 22.

    Mayr J. A.. Spectrum of combined respiratory chain defects. J. Inherit. Metab. Dis. 38, 629–640 (2015 ).

    Not in our library10.1007/s10545-015-9831-y

23. 23.

    Haack T. B.. ELAC2 mutations cause a mitochondrial RNA processing defect associated with hypertrophic cardiomyopathy. Am. J. Hum. Genet. 93, 211–223 (2013 ).

    Not in our library10.1016/j.ajhg.2013.06.006

24. 24.

    Haack T. B.. Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency. Nat. Genet. 42, 1131–1134 (2010 ).

    Not in our library10.1038/ng.706

25. 25.

    Li Y. I.. RNA splicing is a primary link between genetic variation and disease. Science 352, 600–604 (2016 ).

    Not in our library10.1126/science.aad9417

26. 26.

    Zhang B.. Proteogenomic characterization of human colon and rectal cancer. Nature 513, 382–387 (2014 ).

    Not in our library10.1038/nature13438

27. 27.

    Liu Y., Beyer A. & Aebersold R. On the dependency of cellular protein levels on mRNA abundance. Cell 165, 535–550 (2016 ).

    Not in our library10.1016/j.cell.2016.03.014

28. 28.

    Lee K. K., Shimoji M., Hossain Q. S., Sunakawa H. & Aniya Y. Novel function of glutathione transferase in rat liver mitochondrial membrane: role for cytochrome c release from mitochondria. Toxicol. Appl. Pharmacol. 232, 109–118 (2008 ).

    Not in our library10.1016/j.taap.2008.06.005

29. 29.

    Holzerova E.. Human thioredoxin 2 deficiency impairs mitochondrial redox homeostasis and causes early-onset neurodegeneration. Brain 139, 346–354 (2016 ).

    Not in our library10.1093/brain/awv350

30. 30.

    Guarani V.. TIMMDC1/C3orf1 functions as a membrane-embedded mitochondrial complex I assembly factor through association with the MCIA complex. Mol. Cell. Biol. 34, 847–861 (2014 ).

    Not in our library10.1128/mcb.01551-13

31. 31.

    Andrews B., Carroll J., Ding S., Fearnley I. M. & Walker J. E. Assembly factors for the membrane arm of human complex I. Proc. Natl Acad. Sci. USA 110, 18934–18939 (2013 ).

    Not in our library10.1073/pnas.1319247110

32. 32.

    Pervouchine D. D., Knowles D. G. & Guig R. Intron-centric estimation of alternative splicing from RNA-seq data. Bioinformatics 29, 273–274 (2013 ).

    Not in our library10.1093/bioinformatics/bts678

33. 33.
    Analysis of protein-coding genetic variation in 60,706 humans · 2016

    No notice
34. 34.

    Halperin T., Zheng B., Itzhaki H., Clarke A. K. & Adam Z. Plant mitochondria contain proteolytic and regulatory subunits of the ATP-dependent Clp protease. Plant Mol. Biol. 45, 461–468 (2001 ).

    Not in our library10.1023/a:1010677220323

35. 35.

    Jenkinson E. M.. Perrault syndrome is caused by recessive mutations in CLPP, encoding a mitochondrial ATP-dependent chambered protease. Am. J. Hum. Genet. 92, 605–613 (2013 ).

    Not in our library10.1016/j.ajhg.2013.02.013

36. 36.

    Jenkinson E. M.. Perrault syndrome: further evidence for genetic heterogeneity. J. Neurol. 259, 974–976 (2012 ).

    Not in our library10.1007/s00415-011-6285-5

37. 37.

    Szczepanowska K.. CLPP coordinates mitoribosomal assembly through the regulation of ERAL1 levels. EMBO J. 35, 2566–2583 (2016 ).

    Not in our library10.15252/embj.201694253

38. 38.

    Piva F., Giulietti M., Burini A. B. & Principato G. SpliceAid 2: a database of human splicing factors expression data and RNA target motifs. Hum. Mutat. 33, 81–85 (2012 ).

    Not in our library10.1002/humu.21609

39. 39.

    Dogan R. I., Getoor L., Wilbur W. J. & Mount S. M. SplicePort--an interactive splice-site analysis tool. Nucleic Acids Res. 35, W285–W291 (2007 ).

    Not in our library10.1093/nar/gkm407

40. 40.

    Timmermans M. J. T. N.. Why barcode? High-throughput multiplex sequencing of mitochondrial genomes for molecular systematics. Nucleic Acids Res. 38, e197–e197 (2010 ).

    Not in our library10.1093/nar/gkq807

Cited by papers we hold 11

• Mitochondrial diseases: from molecular mechanisms to therapeutic advances · 2025
  No notice
• Oligonucleotide correction of an intronic TIMMDC1 variant in cells of patients with severe neurodegenerative disorder · 2022
  Not checked
• A guide for the diagnosis of rare and undiagnosed disease: beyond the exome · 2022
  No notice
• Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis · 2022
  No notice
• Clinical implementation of RNA sequencing for Mendelian disease diagnostics · 2022
  No notice
• Finding associations in a heterogeneous setting: statistical test for aberration enrichment · 2021
  Not checked
• Detection of aberrant splicing events in RNA-seq data using FRASER · 2021
  Corrected
• Mitochondrial Structure and Bioenergetics in Normal and Disease Conditions · 2021
  No notice
• Multi-Omics Approaches to Improve Mitochondrial Disease Diagnosis: Challenges, Advances, and Perspectives · 2020
  Not checked
• Long-Read Sequencing Emerging in Medical Genetics · 2019
  No notice
• Recent advances in understanding the molecular genetic basis of mitochondrial disease · 2019
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.